GGrantIndex
Sort

46,585 grants matching heart failure

UFRCC for Cardiovascular Cell Therapy Research Network

$689,587
Carl J Pepine · University Of Florida · UM1 · FY2018 · HL

Plasticity of nTS Output Neurons In Acute and Chronic Hypoxia

$689,539
Eileen M Hasser · University Of Missouri-Columbia · R01 · FY2019 · HL

Drug abuse and HIV-associated pulmonary vascular injury

$689,513
Navneet Kaur Dhillon · University Of Kansas Medical Center · R01 · FY2021 · HL

Targeting the Arrhythmogenic Sources of Human Atrial Fibrillation

$689,501
Vadim V Fedorov · Ohio State University · R01 · FY2022 · HL

Regulation of Vascular Smooth Muscle Cell Phenotype by a Novel Isoform of Glucose-6-Phosphate Dehydrogenase

$689,459
Sachin A Gupte · New York Medical College · R01 · FY2025 · HL

Polymerase Inhibitors of Respiratory Syncytial Virus

$689,381
Richard K. Plemper · Georgia State University · R01 · FY2022 · AI

Polymerase Inhibitors of Respiratory Syncytial Virus

$689,381
Richard K. Plemper · Georgia State University · R01 · FY2024 · AI

Polymerase Inhibitors of Respiratory Syncytial Virus

$689,381
Richard K. Plemper · Georgia State University · R01 · FY2023 · AI

Determining true versus apparent treatment-resistant hypertension among African Americans in the Jackson Heart Study

$689,375
Rikki M Tanner · University Of Alabama At Birmingham · R01 · FY2021 · HL

Functional Genomics of Chemical -Induced Acute Lung Injury

$689,367
George Douglas Leikauf · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · ES

Transendothelial transport and CD36 in the dysregulated lipid trafficking of failing hearts

$689,337
E Douglas Lewandowski · Ohio State University · R01 · FY2025 · HL

Functional Genomics of Atrial Fibrillation in Human Atria

$689,294
Mina Kay Chung · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · HL

Prospective renal insufficiency cohort evaluation: PRICE

$689,292
Raymond R Townsend · University Of Pennsylvania · U01 · FY2019 · DK

Prospective renal insufficiency cohort evaluation: PRICE

$689,292
Debbie L Cohen · University Of Pennsylvania · U01 · FY2022 · DK

Prospective renal insufficiency cohort evaluation: PRICE

$689,292
Raymond R Townsend · University Of Pennsylvania · U01 · FY2020 · DK

Prospective renal insufficiency cohort evaluation: PRICE

$689,292
Debbie L Cohen · University Of Pennsylvania · U01 · FY2021 · DK

Prospective renal insufficiency cohort evaluation: PRICE

$689,292
Raymond R Townsend · University Of Pennsylvania · U01 · FY2018 · DK

Cardioprotective mechanisms of novel noncoding RNA in myocardial infarction

$689,279
Eduardo Marban · Cedars-Sinai Medical Center · R01 · FY2025 · HL

Comprehensive Assessment of Retinal Vasculature (CARV)

$689,276
Vinayak S Joshi · Visionquest Biomedical, Llc · R44 · FY2015 · EY

Plasmonically Enhanced Point-of-care Detection of Cardiac Biomarkers by a Smart Phone

$689,239
Maiken Mikkelsen · Duke University · R01 · FY2020 · HL

Dual targeting chemokine receptors prevents chemotherapy-induced cardiotoxicity

$689,232
Yi Tan · University Of Louisville · R01 · FY2024 · HL

Proteomic determinants of direct measures of insulin sensitivity

$689,217
Themistocles Leonard Assimes · Stanford University · R01 · FY2022 · DK

10-Year Changes in Objectively-Measured Physical Activity and Sedentary Behavior in the CARDIA Cohort

$689,205
Stephen Sidney · Kaiser Foundation Research Institute · R56 · FY2015 · HL

DEPRESSION AND REHOSPITALIZATION IN PATIENTS WITH HEART FAILURE

$689,183
Kenneth E Freedland · Washington University · R01 · FY2015 · HL

Modulation of Mitofusin Activity to Treat Heart Disease

$689,091
Richard N Kitsis · Albert Einstein College Of Medicine · R01 · FY2021 · HL